How to buy Vaxart (VXRT) shares in Australia
Learn how to easily invest in Vaxart shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Vaxart Inc is a biotechnology business with stocks listed in the US. Vaxart shares (VXRT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$8.17 – a decrease of 2.85% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Vaxart
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Vaxart. Find the share by name or ticker symbol: VXRT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Vaxart reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$7.72, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Vaxart, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Vaxart. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Vaxart stock price (NASDAQ:VXRT)Use our graph to track the performance of VXRT stocks over time.
Vaxart shares at a glance
|52-week range||US$3.71 - US$15.8|
|50-day moving average||US$8.6566|
|200-day moving average||US$7.4433|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-0.476|
Where to buy Vaxart stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Vaxart stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Vaxart shares?Before you consider Vaxart, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Vaxart price performance over time
|1 week (2021-09-16)||-0.61%|
|1 month (2021-08-26)||-9.32%|
|3 months (2021-06-25)||-4.33%|
|6 months (2021-03-26)||36.39%|
|1 year (2020-09-25)||10.41%|
|2 years (2019-09-26)||2,669.49%|
|3 years (2018-09-26)||187.68%|
|5 years (2016-09-26)||-60.07%|
Stocks similar to Vaxart
|Revenue TTM||US$1.2 million|
|Gross profit TTM||US$-15,817,000|
|Return on assets TTM||-22.69%|
|Return on equity TTM||-45.05%|
|Market capitalisation||US$1 billion|
TTM: trailing 12 months
Shorting Vaxart shares
There are currently 17.4 million Vaxart shares held short by investors – that's known as Vaxart's "short interest". This figure is 14.6% down from 20.3 million last month.
There are a few different ways that this level of interest in shorting Vaxart shares can be evaluated.
Vaxart's "short interest ratio" (SIR)
Vaxart's "short interest ratio" (SIR) is the quantity of Vaxart shares currently shorted divided by the average quantity of Vaxart shares traded daily (recently around 8.6 million). Vaxart's SIR currently stands at 2.02. In other words for every 100,000 Vaxart shares traded daily on the market, roughly 2020 shares are currently held short.
However Vaxart's short interest can also be evaluated against the total number of Vaxart shares, or, against the total number of tradable Vaxart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaxart's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Vaxart shares in existence, roughly 140 shares are currently held short) or 0.1426% of the tradable shares (for every 100,000 tradable Vaxart shares, roughly 143 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vaxart.
Find out more about how you can short Vaxart stock.
Vaxart share dividends
We're not expecting Vaxart to pay a dividend over the next 12 months.
Have Vaxart's shares ever split?
Vaxart's shares were split on a 1:11 basis on 13 February 2018. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vaxart shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Vaxart shares which in turn could have impacted Vaxart's share price.
Vaxart share price volatility
Over the last 12 months, Vaxart's shares have ranged in value from as little as US$3.71 up to US$15.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaxart's is 0.3903. This would suggest that Vaxart's shares are less volatile than average (for this exchange).
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which completed Phase I clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The company is headquartered in South San Francisco, California.
Vaxart in the news
Vaxart To Present at Upcoming Vaccine Conferences
Vaxart : #8239;To Present at Upcoming Vaccine Conferences
Vaxart To Present at Upcoming Vaccine Conferences
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
Virgin Tasmania flights sale from $49 and double status credits
Virgin Australia launches more direct Tassie services with flexible flights taking off from October 2021.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Ask an Expert